XML 76 R38.htm IDEA: XBRL DOCUMENT

Stockholder's Equity (Tables)

12 Months Ended

Jul. 31, 2020

Schedule of stock options exercised utilizing a cashless exercise

The exercised stock options, utilizing a cashless exercise, are summarized in the following table:


Period	Options Exercised	Weighted Average Exercise Price		Shares Net Settled for Exercise	Shares Withheld for Taxes ⁽¹⁾	Net Shares to Employees	Weighted Average Share Price for Withholding		Employee Stock Based Tax Withholding (in 000s)
FY 2018—Q2	80,000	$	6.54	11,996	—	68,004	$	43.60	$	—
FY 2019—Q3	3,000,000	17.81		945,162	806,039	1,248,799	56.53		45,565
FY 2020—Q1	4,000,000	17.81		865,719	1,231,595	1,902,686	82.29		101,348

(1)Shares withheld for taxes are treated as a repurchase of shares for accounting purposes but do not count against the Company’s stock repurchase program.

Schedule of share-based compensation expense

The following table details stock-based compensation recognized by the Company for stock options and restricted stock awards:


	Year Ended July 31,
(In thousands)	2020		2019		2018
General and administrative	$	17,567	$	18,254	$	19,351
Yard operations	5,755		5,191		3,870
Total stock-based compensation	$	23,322	$	23,445	$	23,221

Schedule of non-vested shares

A summary of the status of the Company’s non-vested shares from stock option awards and its activity during the year ended July 31, 2020 was as follows:


(In thousands, except per share amounts)	Shares	Weighted Average Grant- date Fair Value
Non-vested shares at July 31, 2019	4,209	$	11.05
Grants of non-vested shares	1,175	24.89
Vested	(1,874)	9.98
Forfeitures or expirations	(207)	7.82
Non-vested shares at July 31, 2020	3,303	$	17.58

Schedule of option activity

The following is a summary of activity for the Company’s stock options for the year ended July 31, 2020:


(In thousands, except per share and term data)	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In years)	Aggregate Intrinsic Value
Outstanding as of July 31, 2019	14,552	$	26.29	6.04	$	745,592
Grants of options	1,175	85.45
Exercises	(7,461)	19.15
Forfeitures or expirations	(207)	29.95
Outstanding as of July 31, 2020	8,059	$	41.44	6.72	$	417,529

Exercisable as of July 31, 2020	4,756	$	28.17	5.46	$	309,493

Vested and expected to vest as of July 31, 2020	7,758	$	41.14	6.77	$	404,240

Schedule of restricted stock activity

The following is a summary of activity for the Company’s restricted stock for the for the year ended July 31, 2020:


(In thousands, except per share data)	Restricted Shares	Weighted Average Grant Date Fair Value
Outstanding as of July 31, 2019	134	$	56.62
Grants of restricted stock	68	82.33
Vested restricted stock	(74)	60.74
Forfeited restricted stock	(23)	59.03
Outstanding as of July 31, 2020	105	$	69.86

Schedule of stock options outstanding and exercisable

The following table summarizes stock options outstanding and exercisable as of July 31, 2020:


(In thousands, except per share amounts)				Options Outstanding									Options Exercisable
Range of Exercise Prices				Number	Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number		Weighted Average Exercise Price
$12.48	—	$17.64	259	2.53	$	14.26	258		$	14.25
$17.73	—	$27.93	3,138	4.90	19.81		3,045		19.64
$30.97	—	$36.32	1,393	7.12	35.69		573		35.73
$43.96	—	$88.58	3,269	8.62	66.81		880		56.87
Outstanding as of July 31, 2020				8,059	6.72		$	41.44	4,756		$	28.17